ASSET | DATE | % RETURN |
---|---|---|
Agape ATP Corporation Common Stock (ATPC) | 7/1/2023 - 12/31/2023 | 72,928.57% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 7/1/2023 - 12/31/2023 | 2,112.76% |
Dianthus Therapeutics (DNTH) | 7/1/2023 - 12/31/2023 | 1,305.41% |
Soleno Therapeutics (SLNO) | 7/1/2023 - 12/31/2023 | 860.62% |
Regis Corporation Common Stock (RGS) | 7/1/2023 - 12/31/2023 | 800% |
iCoreConnect Inc Common stock (ICCT) | 7/1/2023 - 12/31/2023 | 726.8% |
Myomo (MYO) | 7/1/2023 - 12/31/2023 | 721.31% |
Safety Shot (SHOT) | 7/1/2023 - 12/31/2023 | 716.28% |
Urgently Inc Common Stock (ULY) | 7/1/2023 - 12/31/2023 | 673.17% |
Oncology Institute (TOIIW) | 7/1/2023 - 12/31/2023 | 616.85% |
Binah Capital Group, Inc Warrants (BCGWW) | 7/1/2023 - 12/31/2023 | 562.25% |
Renovaro Biosciences (RENB) | 7/1/2023 - 12/31/2023 | 480.37% |
Momentus (MNTS) | 7/1/2023 - 12/31/2023 | 437.27% |
Universe Pharmaceuticals (UPC) | 7/1/2023 - 12/31/2023 | 423.44% |
MoneyLion (ML) | 7/1/2023 - 12/31/2023 | 422.42% |
QXO (QXO) | 7/1/2023 - 12/31/2023 | 419.04% |
Direct Digital (DRCT) | 7/1/2023 - 12/31/2023 | 416.67% |
Gyre Therapeutics (GYRE) | 7/1/2023 - 12/31/2023 | 362.88% |
SHF (SHFSW) | 7/1/2023 - 12/31/2023 | 308.78% |
Fresh Grapes LLC (VINE) | 7/1/2023 - 12/31/2023 | 295.65% |
Invivyd (IVVD) | 7/1/2023 - 12/31/2023 | 275.24% |
Tempest Therapeutics (TPST) | 7/1/2023 - 12/31/2023 | 246.46% |
Oncology Institute (TOI) | 7/1/2023 - 12/31/2023 | 240% |
Alarum Technologies (ALAR) | 7/1/2023 - 12/31/2023 | 233.05% |
Journey Medical (DERM) | 7/1/2023 - 12/31/2023 | 231.03% |